Alexion Pharmaceuticals ($ALXN) plans to add 50 new jobs at its new supply chain outpost in Dublin, where the U.S. biotech powerhouse will house a variety of operations to provide customers abroad with its rare disease therapy Soliris. As The Irish Times reports, the company aims to begin shipping the therapy for rare blood disorders from the facility before the end of this year. Ireland, which has been recovering from an economic slowdown, has been hungry for new jobs. Item